Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL765917 | 0.79 | DPP4 (0.35) | TSHRTDP1 | |
| SCHEMBL435431 | 0.79 | ALDH1A1 (0.30) | — | |
| SCHEMBL20224768 | 0.79 | DPP4 (0.35) | TSHRTDP1 | |
| SCHEMBL28438544 | 0.75 | TSHR (0.32) | TSHR | |
| SCHEMBL27564058 | 0.75 | — | — | |
| SCHEMBL23717857 | 0.75 | — | — | |
| SCHEMBL13517575 | 0.75 | — | — | |
| SCHEMBL20118848 | 0.73 | — | — | |
| SCHEMBL4999752 | 0.73 | — | — | |
| SCHEMBL23898839 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 213 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2829555-B1 | METHOD FOR PRODUCING OLEFIN POLYMER | MITSUI CHEMICALS INC (JP) | 2018-05-16 | — | — | EP | claimed |
| CN-104203993-B | Process for producing olefin polymer | 三井化学株式会社 | 2016-06-15 | — | — | CN | claimed |
| US-9315602-B2 | Method for producing olefin polymer | MITSUI CHEMICALS, INC. (JP) | 2016-04-19 | — | — | US | claimed |
| US-12616728-B2 | Processes and systems for converting cannabinoids into cannabinoid derivatives and isolating the same | SUPER CRITICAL IP, LLC (US) | 2026-05-05 | — | — | US | disclosed |
| US-20250152646-A1 | SOLVENTS, METHODS, AND SYSTEMS FOR ISOLATING CANNABINOIDS FROM PLANTS EXTRACTS OR FROM SYNTHETIC PATHWAYS | NOEL ARMAND J (US) | 2025-05-15 | — | — | US | disclosed |
| US-12090185-B2 | Processes for converting cannabinoids into cannabinoid derivatives and recovering the same | SUPER CRITICAL IP, LLC (US) | 2024-09-17 | — | — | US | disclosed |
| EP-3907003-B1 | HALOGEN-CONTAINING COMPOUND AND USE THEREOF AS CATALYST LIGAND IN ETHYLENE OLIGOMERIZATION | CHINA PETROLEUM & CHEM CORP (CN) | 2024-09-04 | — | — | EP | disclosed |
| US-20240082335-A1 | PROCESSES AND SYSTEMS FOR CONVERTING CANNABINOIDS INTO CANNABINOID DERIVATIVES AND ISOLATING THE SAME | SUPER CRITICAL IP, LLC | 2024-03-14 | — | — | US | disclosed |
| US-11872259-B2 | Processes and systems for converting cannabinoids into cannabinoid derivatives and isolating the same | SUPER CRITICAL IP, LLC (US) | 2024-01-16 | — | — | US | disclosed |
| US-11826743-B2 | Halogen-containing compound and use thereof as catalyst ligand in ethylene oligomerization | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2023-11-28 | — | — | US | disclosed |
| US-11759491-B2 | Solvents, methods, and systems for isolating botanical extracts from plants | SUPER CRITICAL IP, LLC (US) | 2023-09-19 | — | — | US | disclosed |
| CN-101495522-A | Modified conjugated diene polymer and method for producing same | ASAHI CHEMICAL CORP (JP) | 2009-07-29 | — | — | CN | disclosed |
| US-5086184-A | Herbicides | DOWELANCO (US) | 1992-02-04 | — | — | US | disclosed |
| US-4943634-A | HERBICIDES | ELI LILLY AND COMPANY (US) | 1990-07-24 | — | — | US | disclosed |
| US-4801718-A | HERBICIDES | ELI LILLY AND COMPANY (US) | 1989-01-31 | — | — | US | disclosed |
| US-4636243-A | HERBICIDES ISOXAZOLES | ELI LILLY AND COMPANY (US) | 1987-01-13 | — | — | US | disclosed |
| US-4515625-A | HERBICIDES | ELI LILLY AND COMPANY (US) | 1985-05-07 | — | — | US | disclosed |
| EP-0049071-B1 | N-ARYLBENZAMIDE DERIVATIVES | ELI LILLY AND COMPANY (US) | 1984-12-19 | — | — | EP | disclosed |
| US-4416683-A | HERBICIDES | ELI LILLY AND COMPANY (US) | 1983-11-22 | — | — | US | disclosed |
| EP-0049071-A1 | N-arylbenzamide derivatives | ELI LILLY AND COMPANY (US) | 1982-04-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12616728-B2 | Processes and systems for converting cannabinoids into cannabinoid derivatives and isolating the same | CNR2, CNR1, SCD | TSHR 2794/4885TDP1 4427/4885 |
| US-11826743-B2 | Halogen-containing compound and use thereof as catalyst ligand in ethylene oligomerization | NOD1, C9, NOD2 | TSHR 613/4885TDP1 1497/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.